Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders.

scientific article published in January 1998

Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID9829013

P2093author name stringSchatzberg AF
Regier DA
Rae DS
Narrow WE
Kaelber CT
P433issue34
P921main subjectcomorbidityQ1414874
P304page(s)24-28
P577publication date1998-01-01
P1433published inThe British journal of psychiatry. SupplementQ27709593
P1476titlePrevalence of anxiety disorders and their comorbidity with mood and addictive disorders

Reverse relations

cites work (P2860)
Q35137665An examination of psychopathology and daily impairment in adolescents with social anxiety disorder
Q44414523Anxiety and depression in the working population using the HAD Scale--psychometrics, prevalence and relationships with psychosocial work characteristics
Q35924378Anxiety and depression: mouse genetics and pharmacological approaches to the role of GABA(A) receptor subtypes
Q48689501Anxiety disorders and comorbid depression in community dwelling older adults.
Q36857965Anxiety, depression and hopelessness in adolescents: a structural equation model
Q55085940Anxiolytic effects of Lippia citriodora in a mouce model of anxiety.
Q35020426Burden of anxiety disorders in pediatric medical settings: prevalence, phenomenology, and a research agenda
Q92433255Cardiorespiratory Fitness Predicts Greater Vagal Autonomic Activity in Drug Users Under Stress
Q36813492Co-morbid anxiety disorders in bipolar disorder and major depression: familial aggregation and clinical characteristics of co-morbid panic disorder, social phobia, specific phobia and obsessive-compulsive disorder
Q55255406Cognitive Deficits Are Attenuated in Neuroglobin Overexpressing Mice Exposed to a Model of Obstructive Sleep Apnea.
Q30973569Comparison of the estimated prevalence of mood and/or anxiety disorders in Canada between self-report and administrative data.
Q35237009Core symptoms of major depressive disorder: relevance to diagnosis and treatment
Q92251706Depressive symptoms are associated with blunted reward learning in social contexts
Q36420660Design and Rationale for a Randomized Controlled Trial Testing the Efficacy of Aerobic Exercise for Patients with Obsessive-Compulsive Disorder
Q91810751Differential Relationships of Child Anxiety and Depression to Child Report and Parent Report of Electronic Media Use
Q37101257Distinct regions of prefrontal cortex mediate resistance and vulnerability to depression
Q33959971Does fetal exposure to SSRIs or maternal depression impact infant growth?
Q35835446Effect of age on the frequency of anxiety disorders in major depression with psychotic features
Q37586106Effectiveness of a Cognitive Behavioral Therapy-Based Indicated Prevention Program for Children with Elevated Anxiety Levels: a Randomized Controlled Trial
Q89900646Effects of repetitive gentle handling of male C57BL/6NCrl mice on comparative behavioural test results
Q45986725Employment frustration and alcohol abuse/dependence among labor migrants in California
Q90409515Examination of the Correlation Between Physical and Psychological Measures in Community-Dwelling Older Adults
Q36531377Examining gender differences for gambling engagement and gambling problems among emerging adults
Q44701365False beliefs: the current treatment of patients with depression
Q35755235Frequency and patterns of psychiatric comorbidity in a sample of primary care patients with anxiety disorders
Q34557801Genetic and environmental influences on the co-morbidity between depression, panic disorder, agoraphobia, and social phobia: a twin study
Q36135959Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.
Q57395897Guided Internet-based cognitive behavioral therapy for mild and moderate depression: A benchmarking study
Q37012607Hazardous drinking, depression, and anxiety among sexual-minority women: self-medication or impaired functioning?
Q35996479High-fat diet transition reduces brain DHA levels associated with altered brain plasticity and behaviour
Q38832608Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond
Q36543425Integrating structural and epidemiological research to inform the classification of psychopathology
Q35924435Intergenerational transmission of chronic physical disease via chronic mental disorders: the potential role of addictive behaviors
Q36810167Lifetime comorbidities between phobic disorders and major depression in Japan: results from the World Mental Health Japan 2002-2004 Survey
Q33684243Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers
Q36901729Long-term use of benzodiazepines in participants with comorbid anxiety and alcohol use disorders
Q24288801Major depression symptoms in primary care and psychiatric care settings: a cross-sectional analysis
Q37235595Managing the patient with co-morbid depression and an anxiety disorder
Q35914709Maternal drug abuse versus maternal depression: vulnerability and resilience among school-age and adolescent offspring
Q36753076Meeting report: "Depression and Anxiety Spectrum disorders: from basic science to the clinic and back"
Q37478347Meta-analysis comparing different behavioral treatments for late-life anxiety
Q34075669Methyl donor-deficient diet during development can affect fear and anxiety in adulthood in C57BL/6J mice
Q37586937Novelty-seeking behavior predicts vulnerability in a rodent model of depression
Q36027999Parent psychopathology and youth internalizing symptoms in an urban community: a latent growth model analysis
Q34229109Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.
Q39005115Potential Antidepressant Constituents of Nigella sativa Seeds.
Q51944252Prevalence and correlates of mental disorders among Native American women in primary care.
Q36238104Prevalence and functional consequences of severe insomnia symptoms in mood and anxiety disorders: results from a nationally representative sample
Q54966434Prospective mental imagery as its link with anxiety and depression in prisoners.
Q35905983Psychological and personality factors in type 2 diabetes mellitus, presenting the rationale and exploratory results from The Maastricht Study, a population-based cohort study.
Q36836847Psychopathology of addiction: May a SCL-90-based five dimensions structure be applied irrespectively of the involved drug?
Q46846893Qualitative changes in symptomatology as an effect of treatment with escitalopram in generalized anxiety disorder and major depressive disorder
Q35663709Quality of life impairments among adults with social phobia: the impact of subtype
Q37111333Refinement of diagnosis and disease classification in psychiatry
Q34133400Reports of drinking to self-medicate anxiety symptoms: longitudinal assessment for subgroups of individuals with alcohol dependence
Q36541539Screening for adolescent anxiety disorders in a pediatric emergency department
Q34091656Social skills and social phobia: an investigation of DSM-IV subtypes
Q36824896Substance use disorders in individuals with body dysmorphic disorder
Q53402428The Effect of Gentle Handling on Depressive-Like Behavior in Adult Male Mice: Considerations for Human and Rodent Interactions in the Laboratory.
Q64265959The Influence of Anxiety on the Recognition of Facial Emotion Depends on the Emotion Category and Race of the Target Faces
Q90049232The Neuroscience of Drug Reward and Addiction
Q48082503The chicken and egg of anxiety and depression.
Q36246174The effects of mindfulness-based cognitive therapy on affective memory recall dynamics in depression: a mechanistic model of rumination
Q33962590The elderly in the psychiatric emergency service (PES); a descriptive study
Q33836454The expanding cognitive-behavioural therapy treatment umbrella for the anxiety disorders: disorder-specific and transdiagnostic approaches.
Q34293707The influence of anxiety on the progression of disability
Q43958257The long-term treatment outcomes of depression and anxiety comorbid with substance abuse
Q33607241Toward the Identification of a Specific Psychopathology of Substance Use Disorders
Q35166440Treatment of co-occurring anxiety disorders and substance use disorders
Q34679817Using latent variable modeling and multiple imputation to calibrate rater bias in diagnosis assessment

Search more.